THE BIOLOGIC SIGNIFICANCE OF CYTOLOGIC ATYPIA IN PROGESTOGEN-TREATED ENDOMETRIAL HYPERPLASIA

被引:175
作者
FERENCZY, A [1 ]
GELFAND, M [1 ]
机构
[1] SIR MORTIMER B DAVIS JEWISH GEN HOSP,DEPT OBSTET & GYNECOL,MONTREAL H3T 1E2,QUEBEC,CANADA
关键词
D O I
10.1016/0002-9378(89)90103-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:126 / 131
页数:6
相关论文
共 28 条
[1]  
AAUSEMS EW, 1985, INT J GYNECOLOGY PAT, V4, P180
[2]  
BEUTLER HK, 1963, AM J OBSTET GYNECOL, V84, P433
[3]  
CHAMLIAN DL, 1970, OBSTET GYNECOL, V36, P659
[4]  
CHRISTOPHERSON WM, 1971, CANCER-AM CANCER SOC, V27, P1005, DOI 10.1002/1097-0142(197105)27:5<1005::AID-CNCR2820270503>3.0.CO
[5]  
2-F
[6]   PREDICTING THE OUTCOME OF ENDOMETRIAL HYPERPLASIA BY QUANTITATIVE-ANALYSIS OF NUCLEAR FEATURES USING A LINEAR DISCRIMINANT FUNCTION [J].
COLGAN, TJ ;
NORRIS, HJ ;
FOSTER, W ;
KURMAN, RJ ;
FOX, CH .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1983, 1 (04) :347-352
[7]  
EICHNER E, 1971, OBSTET GYNECOL, V38, P739
[8]  
FERENCZY A, 1984, OBSTET GYNECOL, V63, P295
[9]  
FERENCZY A, 1988, CONT ISSUES OBSTETRI, V5
[10]   THE ENDOMETRIAL HYPERPLASIAS AND THEIR RELATIONSHIP TO ENDOMETRIAL NEOPLASIA [J].
FOX, H ;
BUCKLEY, CH .
HISTOPATHOLOGY, 1982, 6 (05) :493-510